Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLA2G2A | P14555 | 4/20 | 0.39 |
| ▸ | MVD | P53602 | 1/20 | 0.34 |
| ▸ | MGAM | O43451 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SI | P14410 | 1/20 | 0.33 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.33 |
| ▸ | BTN3A1 | O00481 | 2/20 | 0.32 |
| ▸ | TPI1 | P60174 | 2/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28361908 | 0.87 | MVD (0.37) | MVDMGAMGAASIMGAM2 | |
| SCHEMBL7261083 | 0.79 | BTN3A1 (0.53) | MVDBTN3A1 | |
| SCHEMBL6991478 | 0.78 | MGAM (0.35) | MGAMGAASIMGAM2CES2 | |
| SCHEMBL2627707 | 0.77 | BTN3A1 (0.46) | PLA2G2AMVDMGAMGAASI | |
| SCHEMBL15150489 | 0.77 | PLA2G2A (0.34) | PLA2G2AMVDBTN3A1TPI1 | |
| SCHEMBL160921 | 0.77 | — | — | |
| SCHEMBL3398971 | 0.76 | MGAM (0.33) | MGAMGAASIMGAM2CES2 | |
| SCHEMBL23249688 | 0.75 | TPI1 (0.50) | BTN3A1TPI1 | |
| SCHEMBL23249660 | 0.75 | TPI1 (0.50) | BTN3A1TPI1 | |
| SCHEMBL12374604 | 0.74 | PLA2G2C (0.40) | MVDBTN3A1TPI1CES2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160030596-A1 | GAS-FILLED STABILIZED PARTICLES AND METHODS OF USE | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2016-02-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160030596-A1 | GAS-FILLED STABILIZED PARTICLES AND METHODS OF USE | LIPA, PPARG, LPXN | PLA2G2A 34/4885MVD 3355/4885MGAM 2223/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.